Axonics Sacral Neuromodulation System
by Boston Scientific 2 variants
PMA P180046
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP180046 | Date13 Nov 2019 | StatusActive |
Official records
- FDA PMA database P180046
Recalls
-
- Ongoing Z-0198-2027
Retroactively Reported: 10mL luer lock syringes included in kit may leak , break or experience other issues that may pose a risk to users.
Timeline
- Approved FDA PMA P180046
- Recall initiated FDA recalls Z-0198-2027
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic name
- Stimulator, electrical, implantable, for incontinence
- FDA applicant
- Boston Scientific Corporation
- PMA number
- FDA product code
- EZW
- Device class
- Class III
- Regulation
- 21 CFR Part 876.5270
- Advisory committee
- Gastroenterology, Urology
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Axonics Sacral Neuromodulation System is an implantable electrical stimulator for incontinence, as defined by its generic name and device classification. It is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.
The system is supplied as an implantable device and is intended for use in clinical settings under physician supervision. It has received FDA PMA approval (P180046) and is classified as a Class III device. No information regarding sterility, single-use or reusable status, MRI safety, sizes, or storage is provided in the source data.